1

ADMIT ONE

#DDW17

05 06 17

Your Ticket to AGA's Program at DDW®

A P R O G R A M O F T H E A G A I N S T I T U T E

AGA HIGHLIGHTS

3

Save the Date: DDW® 2018June 2–5, 2018 • Exhibit Dates: June 3–5, 2018 • Washington, DC

Dear Colleagues,Welcome back to Digestive Disease Week® (DDW)! It has been a great year for planning on

the AGA Institute Council. We’ve welcomed our new section, Microbiome & Microbial Diseases in the Gastrointestinal Tract (MMDGT); we’ve worked with the sponsoring

societies to reduce session overlap; we’ve decreased our abstract descriptors to make the submission process more clear; and we’ve expanded our basic science themes across all four days of the meeting.

I encourage you to use the DDW Mobile App to pick a track that you might be interested in and follow our suggestions or navigate on your own. Don’t

miss out on the happenings in the Poster Hall. The ePosters Theater debuts on Saturday and will be available each day from noon until 2 p.m.

I’d also like to announce our next chair-elect, Rhonda F. Souza, MD, AGAF. Rhonda is a true translational scientist — taking the observations from clinical care and mimicking these in her laboratory, which focuses on esophageal cancer. She has served on the council as chair of the gastrointestinal oncology section and made sure that the broad clinical and basic science interests of this group were represented.

Because AGA wants to ensure that basic science investigators are well represented at DDW, we formed a subcommittee to make sure AGA programming and special events fostered young and senior investigators in AGA. She has shown her terrific leadership skills as head of this subcommittee within the council. Rhonda will be a wonderful leader for the council and will continually evolve the council to keep DDW the best GI meeting of the year.

If you have not already registered for DDW, I encourage you to do so today. You can view detailed information about the meeting and register at www.ddw.org. I look forward to seeing you in Chicago.

Maria T. Abreu, MD, AGAF AGA Institute Council Chair

Meet the AGA Institute Council Chair-ElectI LOVE DDW, and I am honored and excited to have been chosen as the next AGA

Institute Council chair. My goal is to create a DDW meeting that will invigorate and energize the minds of clinicians and scientists, both young and seasoned, reassuring them that their choice of a career in gastroenterology was the right one. I will work with council members to create unique and non-redundant programming that will challenge unsubstantiated dogma, showcase cutting-

edge concepts and technologies, and highlight developments that impact clinical practice, making DDW the “must attend” professional meeting each year.

TABLE OF CONTENTSSaturday Sessions ........................................... 4

Sunday Sessions ............................................. 6

Monday Sessions ............................................ 8

Tuesday Sessions .......................................... 10

Committee-Sponsored Symposia ................. 12

Ticketed Sessions .......................................... 13

Basic Science Zone ....................................... 14

AGA Postgraduate Course

and Research Mentor Awards ...................... 17

Practitioner Picks ........................................... 18

Cross-Societal Programming ......................... 20

DDW Tracks ................................................... 21

Poster Sessions ..............................................22

For the most up-to-date information on sessions, please visit www.ddw.org.

Rhonda F. Souza, MD, AGAF AGA Institute Council Chair-Elect

Special Thanks!Thank you to the AGA Institute Council for sponsoring this publication and for continuing to

promote the highest quality scientific knowledge for GI clinicians and researchers.

4 5

8–9:30 a.m. 10–11:30 a.m.CMG ��Intestinal Stem Cell Biology (Room S101a) �Intestinal Stem Cell Responses to Pathogen Infection

(Room S101b)

CP �Gastroenterology in the Age of Trump (Room S100c) �Colorectal-Cancer Screening and Outcomes (Room S406b)

EGD�GERD: Diagnostic Testing (Room S403b)

�Mechanisms of Host-Mucosal Response to Injury and H. pylori Infection (Room S105bcd)

�New Insights Into the Pathogenesis and Treatment of Eosinophilic Esophagitis (Room S102abc)

GDCH

GIONC �Inflammation and Inflammatory Pathways in GI Carcinogenesis (Room S104)

�Clonal and Stem Cell Populations in GI Carcinogenesis (Room S105a)

IAT �Screening for Barrett's Esophagus: Which Test in Which Patient (Room S405)

IDAcute Chronic Diarrhea and Treatment Guidelines (Room S405)

Barrier Functions in the Intestine and Beyond (Room S105a)Epithelial Biology and the Stress Response (Room S104)

IMIBDBasic Science Solving Clinical Conundra in IBD (Room S102abc)

IBD: Diagnosis and Diagnostics (Room S406a)

IBD: Natural History (Room S406a)

Preclinical Treatments in Animal Models of IBD (Room S102d)

LB �Metabolic Diseases of the Liver in Adults (Room S102d) Natural History of Viral Hepatitis (Room S106)

MMDGT �Dietary Modulation of Host-Microbe Interactions in Health and Disease (Room S101b)

NGM ��Novel Diagnostic Approaches and Treatment of Anorectal Dysmotility (Room S103)

��Food Intolerance, Medicinal Foods, Diet Fads and Role of Nutritionists in Gas and Bloating and IBS (Room S100c)

OMN �GI Disease and Nutrition Support: Basic and Clinical Studies (Room S403a) �Endobariatric Techniques: What's New? (Room S103)

PAN ��Post-ERCP Pancreatitis (Room S406b) ��Basic Science and Research in Pancreatic Disorders (Room S101a)

2–3:30 p.m. 4–5:30 p.m.CMG ��Mechanisms of Mucosal Repair (Room S105a) ��Human Organoid Models of Gut Function

and Pathogenesis (Room S101b)

CP�Epidemiology and Control of Esophageal and Gastric Cancers

(Room S105bcd)

��Taking the Pain Out of Dyspepsia Management (Room S106)

��Endoscopic Quality (Room S403b)

��Linking Quality and Reimbursement in IBD (Room S105bcd)

EGD �Measuring Quality of Care in GERD, Barrett’s, EoE and Functional Dyspepsia (Room S501)

�2017 Update on the Management of Eosinophilic Esophageal and Gastric Disorders (Room S402)

�Kristin and David Peura, MD, Lecture: Help! I Can't Get Rid of H. Pylori (Room S502)

GDCH

GIONC �Translational and Targeted Therapies for GI Cancers (Room S104)

�Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics (Room S106)

�The Tumor Microenvironment: Novel Pathways Driving Carcinogenesis (Room S101a)

IAT�Advanced Technology for the Diagnosis of GI Disease:

Sniff, Scope, Stain or Stiffness? (Room S105a)

�Lumen-Apposing Stents: Where Now? (Room S100c)

ID Food Intolerance (Room S406a) Epithelial Biology in Intestinal Disease (Room S403a)

IMIBD IBD: Therapeutic-Drug Monitoring (Room S100ab) IBD: Uncontrolled Observations in Humans (Room S100ab)

LB �Advances in Pathogenesis and Treatment of Alcoholic Hepatitis (Room S101a)

MMDGT�At the Frontier of Microbiome Research (Room S101b)

�Microbial Regulators of the Gut-Brain Function (Room S403a)�Clostridium difficile Colitis: Pathogenesis, Diagnosis,

Management and Therapy (Room S102abc)

NGM��Advances in Diagnosis and Treatment of IBS (Room S406a)

��Constipation and Colorectal Disorders (Room S406b)

OMN �Vitamin D and GI Disease (Room S102d)

PAN ��Chronic Pancreatitis, Diabetes and Pancreatic Cancer: NIH Consortium (Room S406b)

SATURDAY, MAY 6POSTER SESSIONS 9:30 A.M.–4 P.M.

SATURDAY, MAY 6

n LB – Liver & Biliary

n MMDGT – Microbiome & Microbial Diseases

in the Gastrointestinal Tract

n NGM – Neurogastroenterology & Motility

n OMN – Obesity, Metabolism & Nutrition

n PAN – Pancreatic Disorders

To search for sessions and abstracts or to customize your itinerary, visit www.ddw.org.

POSTER SESSIONS 9:30 A.M.–4 P.M.

Distinguished Abstract Plenary

Saturday, May 6, 20174–5:30 p.m.• Kristin and David Peura, MD, Lecture: Help! I Can't Get Rid of H. pylori (Room S502)

SPECIAL NAMED SESSIONS

KEY n CMG – Cellular & Molecular Gastroenterology

n CP – Clinical Practice

n EGD – Esophageal, Gastric & Duodenal Disorders

n GDCH – Growth, Development & Child Health

n GIONC – Gastrointestinal Oncology

n IAT – Imaging & Advanced Technology

n ID – Intestinal Disorders

n IMIBD – Immunology, Microbiology & Inflammatory Bowel Diseases

6 7

8–9:30 a.m. 10–11:30 a.m.CMG

CP ��FIT to be Screened (Room S403b)

EGD �GERD and Barrett's Esophagus: Medical, Surgical and Endoscopic Therapies (Room S501)

GDCH�Controversies in Pediatric IBD (Room S502)

�Organoids as Models of Pediatric Intestinal Disorders (Room S102d)

GIONC�Cancer Epidemiology and Genetics (Room S104)

�Using CRISPR/Cas9 to Develop Novel Models for GI Cancer (Room S101b)

IAT �Imaging in Crohn's Disease: An Emerging Consensus on Use of CT and MR Enterography (Room S102abc)

�New Frontiers in Imaging of GI Disease (Room S105a)

IDIon and Solute Transport (Room S105a)

Irritable Bowel Syndrome (Room S103)

Celiac Disease — Molecular Pathogenesis (Room S102abc)

Super Resolution Light Microscopy (Room S101b)

IMIBD ��IBD: Comparative Effectiveness Studies (Room S100c)��IBD: Dysplasia and Other Disease Complications (Room S100c)

��IBD: Genomics and Gene Function (Room S105bcd)

LB �Treatment of Non-Alcoholic Steatohepatitis (Room S405)

MMDGT

NGM �Gastroesophageal Reflux Disease: Toward Consensus in Terminology and Testing (Room E350)

OMN �Obesity: Basic and Clinical Studies (Room S503)

PAN ��Cellular Cross — Talk in the Pathogenesis of Pancreatic Disease (Room S102d) ��Clinical Acute Pancreatitis (Room S106)

2–3:30 p.m. 4–5:30 p.m.CMG ���Cellular & Molecular Gastroenterology Distinguished Abstract Plenary

and Section Business Meeting (Room S105a)

CP ��Beyond Sporadic Colorectal Cancer and Esophageal Adenocarcinoma: Controversies in Screening for the "Other" GI Cancers (Room S501) ��Upper GI Bleeding and Appropriate Use of PPIs (Room S403b)

EGD

�Barrett's Esophagus: Diagnosis, Management and Surveillance (Room E350)

�Kyoto Global Consensus on H. pylori Infection: Treatment Update, Gastritis Grading, and Definition of H. pylori Dyspepsia (Room S405)

GDCH �Pediatric Management of Upper GI Tract Disorders (Room S106)

GIONC �Cancer Microenvironment and Models (Room S101b)

IAT

ID

IMIBD��IBD: Cytokines, Signaling and Receptors (Room S105bcd)

��The Pregnant Patient With IBD: Data for an International Consensus?! (Room E354a)

���IBD: Adverse Events Related to Therapy (Room E354a)

LB �The Dr. Charles S. Lieber Lecture — Mechanisms of Liver Injury in NAFLD and NASH (Room S403b)

MMDGT�Gut Microbiota in Disease: Identifying Personalized Approaches in

Management of Disease and Section Business Meeting (Room S102abc)

�Role of the Gut Microbiome in Immune and Inflammatory Diseases (Room S105bcd)

NGM�Brain-Gut Axis (Room S502)

�Josephine and Michael Camilleri, MD, Lecture — Motility Matters 2017: An Interactive Forum to Debate What Progress the Field Has Made in the Treatment of GI Motility Disorders (Room S106)

��Neurogastroenterology & Motility Distinguished Abstract Plenary (Room S104)

OMN �Bariatric "Sans" Surgery? Can Changes in Physiology From Bariatric Surgery Inform Treatment of Obesity and Diabetes Without the Surgery? (Room S104)

PAN ��New Horizons in Cystic Fibrosis–Related GI Diseases (Room S401) ��Alcohol: A Wonderful Elixir! Benefits and Effects on Pancreas and Liver (Room S501)

SPECIAL NAMED SESSIONSThe AGA Institute Council works with other societies and donor families to develop additional invited speaker sessions.

Sunday, May 7, 20178–9:30 a.m.• Morton I. Grossman Distinguished Lectureship —

Regulation of Mucosal Growth: Amino Acids to mTOR to Antizyme (Room S104)

10–11:30 a.m.• Funderburg Symposium: 25 Years of Gastric Cancer

Research (Room S101a)

SUNDAY, MAY 7POSTER SESSIONS 9:30 A.M.–4 P.M.

SUNDAY, MAY 7POSTER SESSIONS 9:30 A.M.–4 P.M.

Sunday May 7, 4–5:30 p.m. This year's basic science plenary will feature six abstracts covering topics in IBD, intestinal disease and intestinal response.Room S102abc

AGA BASIC SCIENCE PLENARY2–3:30 p.m.• GRG Spring Symposium: Engineered T Cells and Immune-

Checkpoint Therapies for GI Cancers (S101b)• Josephine and Michael Camilleri, MD, Lecture —

Motility Matters 2017: An Interactive Forum to Debate What Progress the Field Has Made in the Treatment of GI Motility Disorders (S106)

• Rodger C. Haggitt Gastrointestinal Pathology Society Symposium — Getting the Most Out of Your Pathologist: Three Illustrative Cases (E350)

• The Dr. Charles S. Lieber Lecture — Mechanisms of Liver Injury in NAFLD and NASH (S403b)

Certificates of RecognitionEarly Career GIs selected for abstract presentation will be recognized in sessions throughout the entirety of the meeting.

8 9

8–9:30 a.m. 10–11:30 a.m.CMG �Role of Epigenetic-Transcriptional Networks in the Pathogenesis of the GI

Tract (Room S101b)�Mechanisms of Bile Acids in Intestinal Disorders

(Room S105a)

CP��Costs and Patient-Reported Outcomes of Functional Gastrointestinal Disorders

(Room S503)

��Taking Back Power: Options for Organizing Physicians to Enhance Bargaining Power (Room S105a)

��Outcomes in IBD (Room S100c)

EGD �GERD: Complications and Extraesophageal Presentations (Room S503)

GDCH �Microbiome in Pediatric Diseases (Room S102abc) �Response of the Intestine to Normal and Abnormal Stimuli (Room S102d)

GIONC �Esophageal Squamous Cell Cancers: From Genomic Landscapes to Perspectives on New Therapies (Room S104)

�Barrett's Esophagus and Esophageal Adenocarcinoma-Mechanisms and Models (Room S104)

�Systems Biology Approaches to Gastrointestinal Cancer (Room S101b)

IAT �Imaging and Advanced Technology of the Pancreas (Room S403b)

IDCeliac Disease in the Postbiopsy Era (Room S501)

Epithelial Cell Biology — Junctions and Barrier Function (Room S102d)

Managing the Host-Pathogen Interface: Epithelial Innate Immunity (Room S102abc)

IMIBD ��IBD: Quality of Life and Quality of Care (Room S105bcd) ��Immune-Cell Function in IBD (Room S105bcd)

LB �HIV and Liver Disease (Room S403b)

MMDGT

NGM �Gastroparesis: Symptoms, Pathophysiological Mechanisms and Implications for Treatment (Room S100c)

�Enteric Neurobiology: Cell and Molecular Biology (Room S101a)

OMN �Fad Diets: Are You Up to Date? (Room S106) �New Bariatric Therapies for Obesity: Surgical and Nonsurgical (Room S502)

PAN ��Clinical Chronic Pancreatitis (Room S501)

2–3:30 p.m. 4–5:30 p.m.CMG �Inflammatory Mechanisms Regulating Colitis (Room S104) �Basic Mechanisms in Enteric Neurosciences (Room S104)

CP ��Barrett's Esophagus: Management for the General Endoscopist (Room S105bcd)

EGD �Peptic Ulcer Disease and Non-Variceal UGI Bleeding (Room S501) �Mechanisms, Diagnosis and Management of Esophageal Disorders (Room S502)

GDCH �New Frontiers in Pediatric Liver Disease (Room S101a)

GIONC�Cancer Therapy and Chemoprevention (Room S102d)

�Early Onset and Hereditary Colorectal Cancer (Room S105a)���Gastrointestinal Oncology Distinguished Abstract Plenary and

Section Business Meeting (Room S105bcd)

IAT

ID Celiac Disease — Clinical/Epidemiology (Room S102abc)

IMIBD��Kiron and Kamala Das Symposium — Managing the Inpatient With Severe

Ulcerative Colitis: A Case-Based, Medical-Surgical Approach (Room E354a)

��Systems Biology in IBD: A Pathway to a Cure? (Room S102abc)

��� Immunology, Microbiology & Inflammatory Bowel Diseases Distinguished Abstract Plenary and Section Business Meeting (Room E354a)

LB�AGA Emmet B. Keeffe Symposium — Prevention of Viral

Hepatitis Through Vaccination: Done or Just Getting Started? (Room S50)

MMDGT �Dark Matter: Nonbacterial Kingdoms of the Microbiome (Bacteriophage, Archea and Fungi) (Room S101b)

�Unraveling Extra-Intestinal Host-Microbiome Systems Biology: Terra Incognita to Cognita (Room S101b

NGM �Oropharyngeal and Esophageal Dysmotility (Room S502) �IBS Pathophysiology: Cells, Barriers and Motility (Room S102d)

OMN �Hot Topics in Mom-and-Baby Nutrition (Room S105a)

PAN ��Pancreas Cysts, IPMN and NET (Room S403b) ��Total Pancreatectomy and Auto Islet Transplantation (Room E350)

MONDAY, MAY 8POSTER SESSIONS 9:30 A.M.–4 P.M.

MONDAY, MAY 8POSTER SESSIONS 9:30 A.M.–4 P.M.

SPECIAL NAMED SESSIONS AGA PRESIDENTIAL PLENARYMonday, May 8, 10 a.m.–NoonAGA will present an engaging plenary program through a blended series of abstract presentations and invited speaker talks on topics including celiac disease, IBD, and hepatitis B. There will also be a brief address from AGA Institute President Timothy C. Wang, MD, AGAF. (Room S406) AGA BUSINESS MEETING

Monday, May 8, 20178–9:30 a.m.• Controversies in IBD: Resolving Clinical Dilemmas Using

Cochrane Reviews (Room S406)

2–3:30 p.m.• Kiron and Kamala Das Symposium — Managing the

Inpatient With Severe Ulcerative Colitis: A Case Based, Medical-Surgical Approach (Room E354a)

4–5:30 p.m.• AGA Emmet B. Keeffe Symposium — Prevention of Viral

Hepatitis Through Vaccination: Done or Just Getting Started? (S501)

Monday, May 8, 20172–3:30 p.m.(Room E350)

10 11

8–9:30 a.m. 10–11:30 a.m.CMG �Molecular and Cellular Mechanisms of GI Cancers (Room S105bcd) �In Vivo (Non-Human) Models of GI Disorders (Room S102d)

CP ��Colorectal-Cancer Screening Cage Matches (Room S100c) ��� Clinical Practice Distinguished Abstract Plenary (Room S502)

EGD �� Esophageal, Gastric & Duodenal Disorders Distinguished Abstract Plenary: The Best of Barrett's, EoE, GERD, H. pylori (Room S104)

�Cough, Laryngitis and Post-Lung Transplant Rejection: Is it GERD? What Is the Role of a Gastroenterologist in Diagnosis and Management? (Room S501)

�H. pylori Epidemiology, Outcomes and Treatment (Room S503)

GDCH�Not Just Cancer! Wnt/Beta-Catenin During Development and Homeostasis

of the GI Tract (Room S101a)

�Pediatric Functional and Motility Disorders (Room S502)

GIONC�Colon Cancer Biomarkers and Screenings (Room S402)

�Carcinoid and Other GI Neuroendocrine Tumors (Genetics, Epigenetics, Cell Biology and Development) (Room S105a)

IAT �Imaging and Staging of Rectal Cancer — CT, MR and EUS — Best Approach (Room S102abc)

ID ��Measuring Outcome in Therapies for Celiac Disease (Room S106) ��Host Determinants of Gut Microbial Community Structure and Function (Room S101a)

IMIBD ��Farron and Martin Brotman, MD, Lecture — The Modern Medical Management of IBD: Biologics, Biosimilars and Small Molecules (Room E354a) ��IBD: Controlled Clinical Trials (Room E354a)

LB �Harm Reduction in Viral Hepatitis (Room S503) �Updates on Clinical Biliary Tract Disorders in Adults (Room S106)

MMDGT �Gut Feelings: The Microbiome-Gut-Brain Axis (Room S101b) �Lessons From Childhood: The Role of the Gut Microbiome in Pediatric Diseases (Room S104)

NGM �Functional Dyspepsia: Bile Salts, Eosinophils and Novel Treatments (Room S406a)

�Achalasia and Esophagogastric Junction Obstruction: Diagnosis and Treatment (Room S403b)

�Enteric Neurobiology: Pharmacology and Physiology (Room S101b)

�Insights From Community Ecology and Novel Applications to Understanding the Human Microbiome (Room S102abc)

OMN �Hot Topics in Parenteral Nutrition (Room S403b)

PAN ��Pancreatic Cancer: Risk Factors, Biomarkers and Diagnosis (Room S100c)

2–3:30 p.m. 4–5:30 p.m.CMG

CP

EGD �GERD, Achalasia and EOE (Room S503) �Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis (Room S105a)

GDCH �Pediatric IBD: Clinical and Translational Studies (Room S403b)

GIONC �US and International Colorectal Cancer Screening Guidelines (Room S501)

IAT �Advances in Pancreatic Endoscopy (Room S502)

ID��Drug-Induced Latrogenic Diarrhea (Room S105a)

��Microbial-Induced Mucosal Inflammation and Immunity and Host Defense (Room S101a)

IMIBD��Clinical Impact of the Microbiome in IBD: Almost Ready for Prime Time?

(Room S105bcd)

��IBD: Controlled Clinical Trials, Part Two (Room S406)��IBD: Disease Activity Assessment (Room S406)

LB �Noninvasive Diagnosis of NASH (Room S403b)

MMDGT �Clostridium difficile Colitis: When Good Bugs Go Bad (Room S104) �The Gut Microbiome in Pediatric Development and Disease (Room S101a)

NGM

�Intraluminal Factors in the Pathogenesis of Functional Bowel Disorders: Bile Salts, Mast Cells, Proteases and Metabolomics (Room S101b)

�Sensory Neurobiology, Visceral Nociception and Neuroimmunology (Room S102d)

�Small Bowel Dysmotility and Food Intolerance (Room S106)

�New Frontiers in Sensory Neurobiology, Visceral Nociception and Neuroimmunology (Room S101b)

OMN

PAN

TUESDAY, MAY 9 TUESDAY, MAY 9POSTER SESSIONS 9:30 A.M.–4 P.M. POSTER SESSIONS 9:30 A.M.–4 P.M.

SPECIAL NAMED SESSIONSTuesday, May 9, 20178–9:30 a.m.• Farron and Martin Brotman, MD, Lecture — The Modern

Medical Management of IBD: Biologics, Biosimilars and Small Molecules (Room E354a)

A Note to Our ReviewersThe AGA Institute Council thanks you for your commitment to our abstract review process. Without your time and dedication, we would not be able to provide our attendees with such robust fora programming.

To volunteer to review abstracts, visit www.gastro.org/council.

THANK YOU NOTE TO REVIEWERS

12 13

In addition to the program developed by the council, there are a number of sessions that are established and sponsored by various committees within the AGA Institute.

Saturday, May 610–11:30 a.m.• AGA Clinical Guidelines: 2017 Highlights and Guideline

Author Panel Discussion (Room S105bcd)• Empowerment, Success and Safety of Women in

Gastroenterology (Room S403a)

2–3:30 p.m.• Practical Guidelines for the Physician Innovator

(Room S403b)

Sunday, May 78–9:30 a.m.• A Clinician's Guide to FMT: Practical Advances and

Challenges (Room S105bcd)• Advances in Regenerative Medicine for GI Disorders

(Room S101a)• Clinical Trials in Special Populations (Room S502)

10–11:30 a.m.• AGA-Rome Lectureship: Applications of Novel Diagnostic

Modalities in the Diagnosis, Pathophysiology and Treatment Response of Functional GI Disorders (Room E354a)

• Making MACRA Work for Your Practice: The Shift to Value-Based Care (Room S104)

• Microbiome Active Learning Session 200: The Nonbacterial Gut Microbiome in Health and Disease (Room S501)

2–3:30 p.m.• AGA/UEG Rising Scholars: Advances in Research,

a Multitopic Discussion (Room S101a)• Physician Burnout: Recognize and Strive for Wellness

(Room S102d)

4–5:30 p.m.• Advancing Clinical Practice: GI Fellow–Directed Quality-

Improvement Projects (Room S100c)• East-Meets-West Microbiome (Room S105a)• Staying Relevant in a Changing Landscape of GI

(Room S102d)• The Law and Being Sued (Room S101a)

Monday, May 88–9:30 a.m.• Best of UEG Week at DDW (Room S502)• Tele-Ethics: Responsibly Communicating With Patients via

Media (Room S101a)

10–11:30 a.m.• Closing the Data Gaps: Strategies to Recruit and Retain

Diverse Patient Populations in Clinical Studies (Room S106)

12:30–1:30 p.m.• Career-and Professional-Related Issues (Room S104)

1:30–5:30 p.m.• AGA Board Review Course (Room S106)

2–3:30 p.m.• Multidisciplinary Treatment of Obesity: Success

Through Teamwork (Room S103)

4–5:30 p.m.• Best of AGA at DDW in Chinese (Room S403b)• Innovation in Obesity Treatment — Endoscopic and Practice

(Room S100c)• The Road to Leadership in GI (Room S101a)

Tuesday, May 98–9:30 a.m.• AGA Academy of Educators Plenary Session: Integrating

Education Technology in the Era of Millennial Learners (Room S105a)

• Lo Mejor de DDW (Room S501)• Tales From the Front Lines: How GI Practices Are Using

Quality Measurement to Drive Improvement (Room S102d)

2–3:30 p.m.• Advent of Biosimilar Products in US GI Practice

(Room S102abc)• How to Get Your Paper Published in an AGA Journal

(Room E350)

Committee-SponsoredSymposia Ticketed Sessions

Focused Clinical Updates and Research RoundtablesSunday, May 7, and Monday, May 8, 6:30–7:45 a.m.SESSION FEE: $75 per session, includes continental breakfast LOCATION: Hyatt Regency McCormick Place

These sessions are designed to help you discuss the must-see clinical research and basic science abstracts accepted by AGA for presentation at DDW. Sessions are limited to 40 participants per session, so register today to secure your spot.

Topics include:• Defining the Roles of Cholinergic, Purinergic, Peptidergic

Neurotransmission and Interstitial Cells of Cajal (FC01)• FMT-Clostridium difficile and Beyond, What Does the Future

Look Like? (FC02)• Microbiota-Targeted Therapies for Use in Clinical Practice

(FC06)• Monitoring Drug and Disease Complications in IBD Patients

(FC03)• Novel Translational Models for Studying Enteric

Neuromuscular Physiology (FC04)• Optimizing Current Therapy: Integrating Emerging Therapies

for IBD (FC07)• Pancreas Cysts (FC08)• Pancreatitis (Acute and Chronic) (FC05)• Assessing Efficacy of Treatments in Functional Bowel

Disorders: Is Improvement in Symptoms Sufficient? (FR01)• Careers in IBD Research: Primer for Fellows and Faculty

(FR02)

DDW Breakfast With the ExpertsSunday, May 7–Tuesday, May 9, 6:30–7:45 a.m.SESSION FEE: $75, includes continental breakfastLOCATION: McCormick PlaceDDW’s popular Meet-the-Professors format is now offered in the morning as well. Similar to the traditional lunch sessions, these represent scholarly, dynamic discussions in an informal, small-group atmosphere.

DDW Meet the Professor/Investigator LuncheonsSunday, May 7-Tuesday, May 9, 12:30–1:45 p.m.SESSION FEE: $75, includes lunchLOCATION: McCormick PlaceParticipate in a scholarly, dynamic discussion in an informal, small-group atmosphere.

AGA Poster Tours AGA will host six poster tours led by subject-matter experts. Space is limited for these small group tours around the Poster Hall. Fee: $20

Sunday, May 7, 11:45 a.m.–12:30 p.m. (South Hall)• Celiac Disease (P01)• Colon Cancer Screening (P02)• IBD (P03)

Monday, May 8, 11:45 a.m.–12:30 p.m. (South Hall)• IBS (P04)• Microbiome in Health and Disease (P05)• Obesity: Basic and Clinical Research (P06)

14 15

Saturday, May 68–9:30 a.m.• Barrier Functions in the Intestine and Beyond (S105a)• Basic Science Solving Clinical Conundra in IBD (S102abc)• Dietary Modulation of Host-Microbe Interactions in Health

and Disease (S101b)• GI Disease and Nutrition Support: Basic and Clinical Studies

(S403a)• Inflammation and Inflammatory Pathways in GI

Carcinogenesis (S104)• Intestinal Stem Cell Biology (S101a)• Novel Diagnostic Approaches and Treatment of

Anorectal Dysmotility (S103)

10–11:30 a.m.• Clonal and Stem Cell Populations in GI Carcinogenesis

(S105a)• Epithelial Biology and the Stress Response (S104)• Intestinal Stem Cell Responses to Pathogen Infection

(S101b)• Preclinical Treatments in Animal Models of IBD (S102d)

2–3:30 p.m.• At the Frontier of Microbiome Research (S101b)• Intestinal Metaplasia in the Esophagus and Stomach:

Highlights of the 2016 Freston Conference (S102abc)• Mechanisms of Mucosal Repair (S105a)• Microbial Regulators of the Gut-Brain Function (S403a)• Translational and Targeted Therapies for GI Cancers

(S104)• Vitamin D and GI Disease (S102d)

4–5:30 p.m.• Clostridium difficile Colitis: Pathogenesis, Diagnosis,

Management and Therapy (S102abc)• Epithelial Biology in Intestinal Disease (S403a)• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis

and Clinical Therapeutics (S106)• Human Organoid Models of Gut Function and Pathogenesis

(S101b)• The Tumor Microenvironment: Novel Pathways

Driving Carcinogenesis (S101a)

Sunday, May 78–9:30 a.m.• Cancer Epidemiology and Genetics (S104)• Cellular Cross — Talk in the Pathogenesis of Pancreatic

Disease (S102d)• Ion and Solute Transport (S105a)• Morton I. Grossman Distinguished Lectureship Regulation of

Mucosal Growth: Amino Acids to mTOR to Antizyme (S106)• Using CRISPR/Cas9 to Develop Novel Models for GI Cancer

(S101b)

10–11:30 a.m.• Celiac Disease — Molecular Pathogenesis (S102abc)• Funderburg Symposium: 25 Years of Gastric Cancer Research

(S101a)• IBD: Genomics and Gene Function (S105bcd)• Microbiome Active Learning Session 200: The Nonbacterial

Gut Microbiome in Health and Disease (S501)• Obesity: Basic and Clinical Studies (S503)• Organoids as Models of Pediatric Intestinal Disorders

(S102d)• Super Resolution Light Microscopy (S101b)

2–3:30 p.m.• Bariatric "Sans" Surgery? Can Changes in Physiology From

Bariatric Surgery Inform Treatment of Obesity and Diabetes Without the Surgery? (S104)

• Cellular & Molecular: Brain-Gut Axis (S502)• Cellular & Molecular Gastroenterology Distinguished

Abstract Plenary and Section Business Meeting (S105a)• GRG Spring Symposium: Engineered T Cells and Immune-

Checkpoint Therapies for GI Cancers (S101b)• IBD: Cytokines, Signaling and Receptors (S105bcd)

4–5:30 p.m.• AGA: Basic Science Plenary (S102abc)• Cancer Microenvironment and Models (S101b)• Pediatric Management of Upper GI Tract Disorders (S106)• Neurogastroenterology & Motility Distinguished Abstract

Plenary (S104)

Basic Science Zone Basic Science Zone

Basic science is the foundation for advances made in the GI field, and the council is expanding its efforts at DDW 2017 to address the needs of this important group. This year, our basic science subcommittee has expanded its themes across all four days of the meeting.

Basic science programming will be clustered in McCormick Place. Follow the basic science track in DDW’s Mobile App to navigate the plethora of opportunities for you to attend oral sessions, poster sessions and networking.

Other basic science offerings throughout the meeting:

Time Monday:Systems Biology

Tuesday: Underlying Functional Disorders

8 a.m.Role of Epigenetic-Transcriptional Networks in the Pathogenesis of the GI Tract (Room S101b)

Gut Feelings: The Microbiome-Gut-Brain Axis (Room S101b)

10 a.m. Systems Biology Approaches to Gastrointestinal Cancer (Room S101b)

Enteric Neurobiology: Pharmacology and Physiology (Room S101b)

2 p.m.Dark Matter: Non-Bacterial Kingdoms of the Microbiome (Bacteriophage, Archea, and Fungi) (Room S101b)

Intraluminal Factors in the Pathogenesis of Functional Bowel Disorders: Bile Salts, Mast Cells, Proteases and Metabolomics (Room S101b)

4 p.m.Unraveling Extra-Intestinal Host-Microbiome Systems Biology — Terra Incognita to Cognita (Room S101b)

New Frontiers in Sensory Neurobiology, Visceral Nociception and Neuroimmunology (Room S101b)

JAMES W. FRESTON HIGHLIGHTSMISSED THE 2016 FRESTON CONFERENCE ON INTESTINAL METAPLASIA?

Saturday, May 6, 2-3:30 p.m.Intestinal Metaplasia in the Esophagus and Stomach: Highlights of the 2016 Freston Conference (Room S102ABC)

Check out the highlights session with speakers from the conference

A PROGRAM OF THE AGA INSTITUTE

Time Saturday:Microbiome

Sunday:Inflammation and GI Cancers

8 a.m. Dietary Modulation of Host-Microbe Interactions in Health and Disease? (Room S101b)

Using CRISPR/Cas9 to Develop Novel Models for GI Cancer (Room S101b)

10 a.m. Intestinal Stem Cell Responses to Pathogen Infection (Room S101b)

Super Resolution Light Microscopy (Room S101b)

2 p.m. At the Frontier of Microbiome Research (Room S101b)

GRG Spring Symposium: Engineered T Cells and Immune-Checkpoint Therapies for GI Cancers (Room S101b)

4 p.m.

16 17

Monday, May 88–9:30 a.m.• Epithelial Cell Biology — Junctions and Barrier Function

(Room S102d)• Esophageal Squamous Cell Cancers: From Genomic

Landscapes to Perspectives on New Therapies (Room S104)

• Role of Epigenetic-Transcriptional Networks in the Pathogenesis of GI (Room S101b)

10–11:30 a.m.• Barrett's Esophagus and Esophageal Adenocarcinoma:

Mechanisms and Models (Room S104)• Enteric Neurobiology: Cell and Molecular Biology

(Room S101a)• Immune-Cell Function in IBD (Room S105bcd)• Managing the Host-Pathogen Interface: Epithelial Innate

Immunity (Room S102abc)• Mechanisms of Bile Acids in Intestinal Disorders

(Room S105a)• Response of the Intestine to Normal and Abnormal Stimuli

(Room S102d)• Systems Biology Approaches to Gastrointestinal Cancer

(Room S101b)

2–3:30 p.m.• Cancer Therapy and Chemoprevention (Room S102d)• Dark Matter: Nonbacterial Kingdoms of the Microbiome

(Bacteriophage, Archea and Fungi) (Room S101b)• Inflammatory Mechanisms Regulating Colitis (Room S104)• Systems Biology in IBD: A Pathway to a Cure?

(Room S102abc)

4–5:30 p.m.• Basic Mechanisms in Enteric Neurosciences

(Room S104)• Gastrointestinal Oncology Distinguished Abstract Plenary

and Section Business Meeting (Room S105bcd)• Immunology, Microbiology & Inflammatory Bowel Diseases

Distinguished Abstract Plenary and Section Business Meeting (Room E354a)

Tuesday, May 98–9:30 a.m.• Molecular and Cellular Mechanisms of GI Cancers

(Room S105bcd)• Not Just Cancer! Wnt/Beta-Catenin During Development

and Homeostasis of the GI Tract (Room S101a)

10–11:30 a.m.• Colon Cancer Biomarkers and Screenings (Room S402)• Enteric Neurobiology: Pharmacology and Physiology

(Room S101b)• Host Determinants of Gut Microbial Community Structure

and Function (Room S101a)• In Vivo (Non-Human) Models of GI Disorders (Room S102d)• Lessons From Childhood: The Role of the Gut Microbiome in

Pediatric Diseases (Room S104)• Carcinoid and Other GI Neuroendocrine Tumors (Genetics,

Epigenetics, Cell Biology and Development) (Room S105a)

2–3:30 p.m.• Microbial-Induced Mucosal Inflammation and Immunity and

Host Defense (Room S101a)• Sensory Neurobiology, Visceral Nociception and

Neuroimmunology (Room S102d)

4-5:30 p.m.• New Frontiers in Sensory Neurobiology, Visceral Nociception

and Neuroimmunology (Room S101b)

Basic Science Zone

AGA Institute Council Section Research Mentor AwardsEach year, the council awards individuals for their achievements as outstanding mentors in specific areas of research. Congratulations to the following 2017 recipients!

David H. Alpers, MD, AGAFObesity, Metabolism & Nutrition Award presented at the beginning of the OMN session, Sunday, 2 p.m., in room S104.

Peter A. Banks, MDPancreatic Disorders Award presented at the beginning of the PAN session, Sunday, 10 a.m., in room S106.

Nigel W. Bunnett, PhDCellular & Molecular Gastroenterology Award presented at the beginning of CMG session, Sunday, 2 p.m., in Room S105a.

John F. Cryan, PhD Microbiome and Microbial Diseases in the Gastrointestinal Tract Award presented at the beginning of MMDGT session, Sunday, 2 p.m., in Room S102abc.

Nicholas O. Davidson, MD, DSc, AGAFIntestinal DisordersAward presented at the beginning of ID session, Monday, 10 a.m., in Room S102abc.

Gordon R. Greenberg, MDImmunology, Microbiology & Inflammatory Bowel Diseases Award presented in the middle of IMIBD session, Monday, 4 p.m., in Room E354a.

Raj Goyal, MD Neurogastroenterology & MotilityAward presented in the middle of NGM session, Sunday, 4 p.m., in Room S104.

Paul Erick Hyman, MDGrowth, Development & Child HealthAward presented in the beginning of GDCH session, Tuesday, 8 a.m., in Room S502.

Ernst Johan Kuipers, MD, PhD, AGAFClinical PracticeAward presented at the end of CP session, Tuesday, 10 a.m., Room S502.

Arun J. Sanyal, MDLiver & BiliaryAward presented at the beginning of LB session, Sunday, 2 p.m., in Room S403b.

Prateek Sharma, MDEsophageal, Gastric & Duodenal DisordersAward presented at the beginning of EGD session, Tuesday, 8 a.m., in Room S104.

Kenneth K. Wang, MD, AGAFImaging & Advanced TechnologyAward presented at the beginning of IAT session, Saturday, 4 p.m., in Room S105a.

Jun Yu, MD, PhD, AGAFGastrointestinal Oncology Award presented at the beginning of GIONC session, Monday, 4 p.m., in Room S105bcd.

AGA Postgraduate Courseand Research Mentor Awards

AGA POSTGRADUATE COURSE

OF GI ADVANCES

FULLSC PE

THE

Learn more at pgcourse.gastro.org.

A P R O G R A M O F T H E A G A I N S T I T U T E

Saturday, May 6, 20178:15 a.m.–5:30 p.m.

Sunday, May 7, 20178:30 a.m.–12:35 p.m.

Discover the latest cutting-edge digestive

biology research.

Now in PubMed

Visit CMGHjournal.org.

Practitioner Picks

19

Saturday, May 68–9:30 a.m.• Gastroenterology in the Age of Trump

(Room S100c)• Post-ERCP Pancreatitis (Room S406b)

10–11:30 a.m.• AGA Clinical Guidelines: 2017 Highlights and Guideline

Author Panel Discussion (Room S105bcd)• Empowerment, Success and Safety of Women in

Gastroenterology (Room S403a)• Endobariatric Techniques: What's New? (Room S103)• Food Intolerance, Medicinal Foods, Diet Fads and Role of

Nutritionists in Gas and Bloating and IBS (Room S100c)

• Screening for Barrett's Esophagus: Which Test in Which Patients (Room S405)

2–3:30 p.m.• Chronic Pancreatitis, Diabetes and Pancreatic Cancer: NIH

Consortium (Room S406b)• Measuring Quality of Care in GERD, Barrett's, EoE and

Functional Dyspepsia (Room S501)• Practical Guidelines for the Physician Innovator

(Room S406b)• Taking the Pain Out of Dyspepsia Management

(Room S106)

4–5:30 p.m.• 2017 Update on the Management of Eosinophilic,

Esophageal and Gastric Disorders (Room S402)• Kristin and David Peura, MD, Lecture: Help!

I Can't Get Rid of H. pylori (Room S502)• Linking Quality and Reimbursement in IBD (Room S105bcd)• Lumen-Apposing Stents: Where Now?

(Room S100c)

Sunday, May 78–9:30 a.m.• A Clinician's Guide to FMT: Practical Advances

and Challenges (Room S105bcd)• Gastroesophageal Reflux Disease: Toward Consensus in

Terminology and Testing (Room E350)• Imaging in Crohn's Disease: An Emerging Consensus on Use

of CT and MR Enterography (Room S102abc)

10–11:30 a.m.• Controversies in Pediatric IBD (Room S502)• Making MACRA Work for Your Practice: The Shift to Value-

Based Care (Room S104)• Microbiome Active Learning Session 200: The Nonbacterial

Gut Microbiome in Health and Disease (Room S501)

2–3:30 p.m.• Beyond Sporadic Colorectal Cancer and Esophageal

Adenocarcinoma: Controversies in Screening for the "Other" GI Cancers (Room S501)

• Gut Microbiota in Disease: Identifying Personalized Approaches in Management of Disease and Section Business Meeting (Room S102abc)

• Josephine and Michael Camilleri, MD, Lecture — Motility Matters 2017: An Interactive Forum to Debate What Progress the Field Has Made in the Treatment of GI Motility Disorders (Room S106)

• Physician Burnout: Recognize and Strive for Wellness (Room S102d)

• The Pregnant Patient With IBD: Data for an International Consensus?! (Room E354a)

• Rodger C. Haggitt Gastrointestinal Pathology Society Symposium — Getting the Most Out of Your Pathologist: Three Illustrative Cases (Room E350)

4–5:30 p.m.• Kyoto Global Consensus on H. pylori Infection: Treatment

Update, Gastritis Grading and Definition of H. pylori Dyspepsia (Room S405)

• Staying Relevant in a Changing Landscape of GI (Room S102d)

• The Law and Being Sued (Room S101a)

Monday, May 88–9:30 a.m.• Celiac Disease in the Postbiopsy Era

(Room S501)• Controversies in IBD: Resolving Clinical Dilemmas Using

Cochrane Reviews (Room S406)• Fad Diets: Are You Up to Date? (Room S106)• HIV and Liver Disease (Room S403b)• Taking Back Power: Options for Organizing Physicians to

Enhance Bargaining Power (Room S105a)• Tele-Ethics: Responsibly Communicating With Patients via

Media (Room S101a)

12:30–1:30 p.m.• AGA Career-and Professional-Related Issues

(Room S104)

1:30–5:30 p.m.• AGA Board Review Course (Room S106)

2–3:30 p.m.• Barrett's Esophagus: Management for the General

Endoscopist (Room S105bcd)• Early Onset and Hereditary Colorectal Cancer

(Room S105a)• Kiron and Kamala Das Symposium — Managing the

Inpatient With Severe Ulcerative Colitis: A Case-Based, Medical-Surgical Approach (Room E354a)

4–5:30 p.m.• AGA Emmet B. Keeffe Symposium — Prevention of Viral

Hepatitis Through Vaccination: Done or Just Getting Started? (Room S501)

• Hot Topics in Mom-and-Baby Nutrition (Room S105a)• Innovation in Obesity Treatment — Endoscopic and Practice

(Room S100c)• Mechanisms, Diagnosis and Management of Esophageal

Disorders (Room S502)• The Road to Leadership in GI (Room S101a)

Tuesday, May 98–9:30 a.m.• A Colorectal Cancer Screening Cage Matches

(Room S100c)• Farron and Martin Brotman, MD, Lecture — The Modern

Medical Management of IBD: Biologics, Biosimilars and Small Molecules (Room E354a)

• Hot Topics in Parenteral Nutrition (Room S403b)• Imaging and Staging of Rectal Cancer — CT, MR and EUS

— Best Approach (Room S102abc)• Tales From the Front Lines: How GI Practices Are Using

Quality Measurement to Drive Improvement (Room S102d)

10–11:30 a.m.• Cough, Laryngitis and Post–Lung Transplant Rejection: Is it

GERD? What Is the Role of a Gastroenterologist in Diagnosis and Management? (Room S501)

• Updates on Clinical Biliary Tract Disorders in Adults (Room S106)

2–3:30 p.m.• Advances in Pancreatic Endoscopy (Room S502)• Advent of Biosimilar Products in US GI Practice

(Room S102abc)• Clostridium difficile Colitis: When Good Bugs Go Bad

(Room S104)• US and International Colorectal Cancer Screening Guidelines

(Room S501)

Practitioner PicksBe sure to check out these sessions

geared toward practitioners.Be sure to check out these sessions

geared toward practitioners.

18

2120

Cross-Societal ProgrammingAGA, AASLD, ASGE, SSAT

Saturday, May 68–9:30 a.m.• Personalized Management of GI Cancers (Room S501)

10–11:30 a.m.• Probiotics and the Microbiome (Room S501)

2–3:30 p.m.• Management of the Malignant Colon Polyp, Observation,

Endoscopic or Surgical Resection? (Room S103)

Sunday, May 78–9:30 a.m.• Pancreatic Cysts in 2017: Where Are We and

What Is the Future? (Room S100ab)

10–11:30 a.m.• Modern Approach to Achalasia (Room S103)

2–3:30 p.m.• Recent Advances in Neuroendocrine Tumors of

the Pancreas (Room S402)

4–5:30 p.m.• The Role of New FDA-Approved Approaches in the

Management of Obesity: Intragastric Balloons, Vagal Manipulation and Aspiration Therapy (Room S103)

Monday, May 88–9:30 a.m.• GERD: From Diagnosis to Testing and Therapy (Room S103)

10–11:30 a.m.• Incidental Liver Findings: When to Treat, How to Follow?

(Room S103)

2–3:30 p.m.• The Surgical Management of Obesity (Room S503)

4–5:30 p.m.• Multidisciplinary Interventions for Necrotizing Pancreatitis

(Room S103)

Tuesday, May 98–9:30 a.m.• Management of Obstruction in PSC: When and How to

Intervene (Room S103)

2–3:30 p.m.• Cirrhosis and Surgery: Identifying and Managing

(Room S103)

4–5:30 p.m.• Endoscopic and Surgical Principles in IBD

(Room S103)• Noninvasive Diagnosis of NASH (Room S403b)

Each year, the four sponsoring societies collaborate on sessions that cover broad topics for attendees.

DDW BASIC SCIENCE QUICK SHOTSSaturday, May 6, 4–5:30 p.m.DDW basic science travel awardees provide a brief overview of their abstracts. (Room S102d)

DDW BASIC SCIENCE RECEPTIONSaturday, May 6, 5:30 p.m.Join colleagues to network and find out this year’s travel award recipients.

Basic Science Late-Breaking Abstract PlenarySunday, May 7, 2–3:30 p.m. (Room S503)

LATE-BREAKING ABSTRACTS

(Room S103)

Tuesday, May 9, 2–4 p.m.Discussants from all four societies highlight the best in science at DDW. (Room S100c)

THE BEST OF DDW 2017

DDW Administration

4930 Del Ray Ave.

Bethesda, MD 20814

USA

15tracks

Fifteen tracks provide attendees with the ability to search all 2017 sessions by topic or theme across all societies.

Look for these in all of our attendee resources as you plan for the meeting.

DDW Tracks May 6–9, 2017Exhibit Dates: May 7–9, 2017Chicago, ILMcCormick Place

They include:

1 Basic Science

2 Biliary Tract Diseases

3 Colorectal Diseases

4 Education and Training

5 Esophageal Diseases

6 Functional GI and Motility Disorders

7 Health-Care Delivery, Disparities and Practice Management

8 Inflammatory Bowel Diseases

9 Liver Diseases and Transplantation

10 Microbiome in Gastrointestinal and Liver Diseases

11 Obesity and Nutrition

12 Pancreatic Diseases

13 Pediatric GI

14 Stomach and Small Bowel Disorders

15 Technologies and Procedural Innovations

DDW Tracks

Clinical Science Late-Breaking Abstract Plenary

LATE-BREAKING ABSTRACT PLENARY

Tuesday, May 9, 10–11:30 a.m.

22 23

Saturday, May 6Cellular & Molecular Gastroenterology• Cellular Plasticity and Growth Factors Regulating

Proliferation and Differentiation• Gastric Neoplasms: Biology and Clinical Therapeutics• Stem Cells and Organoids

Clinical Practice• Medical Education and Training• Performance Metrics, Process Improvement and

Implementation Science• Systematic Reviews and Meta-Analysis I

Esophageal, Gastric & Duodenal Disorders• Functional Dyspepsia: Nausea and Vomiting• GERD/Barrett's: Pathogenesis• GERD: Complications and Extraesophageal Presentations• Helicobacter pylori: Epidemiology, Diagnosis and Outcomes• Helicobacter pylori: Treatment and Antimicrobial Resistance

Gastrointestinal Oncology• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis

and Clinical Therapeutics• Inflammation and GI Cancers• Liver and Biliary Carcinoma: Management, Etiology,

Diagnosis and Natural History• Metabolism, Obesity, Microbiome and Nutrition in GI

Cancer Pathogenesis• Pancreatic Neoplasms: Precursors, Biology, Diagnosis

and Therapy

Growth, Development & Child Health• Clinical Pediatric Gastroenterology

Imaging & Advanced Technology• Diagnostic and Therapeutic Applications I• Ex Vivo and In Vivo Imaging for Scientific Research

Applications• Imaging Techniques Including Comparative Studies, Efficacy

and Cost-Effectiveness I• Novel/Experimental Endoscopy

Immunology, Microbiology & Inflammatory Bowel Diseases• IBD: Natural History and Outcomes• IBD: Therapeutic Monitoring• IBD: Uncontrolled Therapeutic Observations in Humans

Intestinal Disorders• Celiac Disease — Diagnosis• Celiac Disease — Outcome• Epithelial Cell Function in Inflammation• Intestinal Injury and Repair: Hypoxia, Radiation and

Inflammation• Ion and Solute Transport

Liver & Biliary• Hepatic Fibrosis, Diagnosis and Treatment• Liver and Biliary Carcinoma: Management, Etiology,

Diagnosis and Natural History

Microbiome & Microbial Diseases in the Gastrointestinal Tract• Clostridium difficile Colitis: Pathogenesis, Diagnosis,

Management and Therapy

Neurogastroenterology & Motility• Anorectal Dysmotility (Including Fecal Incontinence,

Dyssynergia and Pelvic-Floor Disorders)• Esophageal Motility and Dysmotility• Oropharyngeal Dysmotility

Obesity, Metabolism & Nutrition• Intestinal Failure and Therapy: Basic and Clinical• Nutrient Absorption and Intestinal Epithelial Function• Nutritional Support: Enteral and Parenteral• Vitamins and Micronutrients: Basic and Clinical

Pancreatic Disorders• Clinical Acute Pancreatitis• Pancreatitis: Inflammation, Fibrogenesis and Immunology (I)

AGA Institute Council Poster JudgingEarly career GI winners will be announced daily via social media each afternoon! Judging criteria will include scientific merit, visual appeal and presentation skills.

Sunday, May 7Cellular & Molecular Gastroenterology• Basic Mechanisms of Injury and Repair• In Vivo Models of GI Disorders• Transcriptional and Epigenetic Regulation of GI Function

and Disease

Clinical Practice• Health Disparities and Global Health• Health Economics (Cost of Illness, Cost-Effectiveness and

Health Economic Models)• Population Health Screening: Colorectal Cancer, Esophageal

Cancer, Hepatocellular Carcinoma and Other Screening

Esophageal, Gastric & Duodenal Disorders• Barrett's Esophagus: Diagnosis, Management and

Surveillance• Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis

and Clinical Therapeutics• GERD/Barrett's: Medical, Surgical and Endoscopic Therapies• Peptic Ulcer Disease and Non-Variceal UGI Bleeding

Gastrointestinal Oncology• Canceromics: Cancer Genomics, Epigenomics,

Metabolomics, Proteomics and Systems Biology• Colon Cancer Screening• Familial Cancer Syndromes and Cancer Genetics• Translational and Targeted Therapies for GI Cancers• Tumor Cell Biology and Microenvironment

Growth, Development & Child Health• Biotics in Health and Disease• Food Intolerances• Genetics and Intestinal Disorders• GI Tract Functions and Their Changes Throughout

the Life Span• In Vivo Models of GI Disorders• Molecular Mechanisms of Growth and Development of the

GI Tract, Liver and Pancreas• The Gut Microbiome in Pediatric Development and Disease

Imaging & Advanced Technology• Confocal Endomicroscopy and Other Optical Sectioning

Techniques I• Diagnostic and Therapeutic Applications II• Imaging Techniques Including Comparative Studies, Efficacy

and Cost-Effectiveness II

Immunology, Microbiology & Inflammatory Bowel Diseases• Animal Models: Preclinical Treatment of Intestinal

Inflammation• Clinical Trials Modulating the Microbiome in IBD• IBD: Adverse Events Related to Therapy• IBD: Comparative Effectiveness Studies• IBD: Controlled Clinical Trials in Humans• IBD: Diagnostics in IBD• IBD: Innate and Adaptive Lymphoid Activation

and Regulation• Pediatric IBD: Clinical and Translational Studies

Intestinal Disorders• Celiac Disease — Population Studies• Celiac Disease — Treatment and Diet Adherence• Cell and Molecular Biology of Intestine• Epithelial Junctions and Barrier Function• In Vivo and Organoid Models of GI Disorders

Liver & Biliary• Clinical Biliary Tract Disorders, Stone Diseases

and Stone Pathogenesis

Microbiome & Microbial Diseases in the Gastrointestinal Tract• Gut Microbial Dysbiosis: Causes and Consequences• Role of the Gut Microbiome in Immune and

Inflammatory Diseases

Neurogastroenterology & Motility• Constipation and Other Functional Colonic Syndromes• Gastroparesis• Pediatric Functional and Motility Disorders• Small Bowel Motility and Food Intolerance

Obesity, Metabolism & Nutrition• New Therapies for Obesity: Preclinical and Clinical• Surgical and Endoscopic Treatment of Obesity

Pancreatic Disorders• Pancreatic Cancer, Endoscopy, Imaging and Acute

Pancreatitis

Poster SessionsPOSTER SESSIONS 9:30 A.M.–4 P.M.POSTER SESSIONS 9:30 A.M.–4 P.M.

Poster SessionsPOSTER SESSIONS 9:30 A.M.–4 P.M.

24 25

Monday, May 8Cellular & Molecular Gastroenterology• Cell Signaling in Inflammation• Enteric Neuroscience and Chemosensing in the GI Tract• Genetics and Intestinal Disorders

Clinical Practice• Patient-Reported Outcomes: IBD, GERD, Functional Disorders

and Other• Systematic Reviews and Meta-Analysis II

Esophageal, Gastric & Duodenal Disorders• Esophageal Motility and Dysmotility• GERD: Diagnostic Testing• Helicobacter pylori-Host Response and Pathogenesis

Gastrointestinal Oncology• Cancer Prevention and Chemoprevention• Carcinoid and Neuroendocrine Neoplams: Biology,

Diagnosis and Clinical Therapeutics• Esophageal and Junctional Neoplasms: Precursor Lesions,

Biology, Diagnosis and Clinical Therapeutics• Molecular Mechanisms and Pathways in Carcinogenesis

and Metastasis

Growth, Development & Child Health• Pediatric Functional and Motility Disorders

Imaging & Advanced Technology• Enhanced Endoscopic Imaging (Including Molecular Imaging,

Spectroscopy and Fluorescence Imaging, and Optical-Coherence Tomography)

• Imaging and Therapeutic Interventions in Obesity and Metabolic Diseases

Immunology, Microbiology & Inflammatory Bowel Diseases• IBD: Cytokines, Signaling and Receptors• IBD: Disease Activity Assessment• IBD: Disease Complications• IBD: Practice Management, Quality of Care and Quality

Assurance• IBD: Quality of Life and Psychosocial Care

Intestinal Disorders• Diarrheal Disease and Other Enteropathies• Inflammation and GI Cancers

Liver & Biliary• Metabolic and Genetic Liver Disease• Non-Alcoholic Fatty Liver Diseases and NASH

Microbiome & Microbial Diseases in the Gastrointestinal Tract• Gut Microbiome in Health and Disease• Microbial Pathogens of the Intestine and Colon

Neurogastroenterology & Motility• Enteric Neurobiology: Pharmacology and Physiology• Irritable Bowel Syndrome: Clinical• Irritable Bowel Syndrome: Pathophysiology• Sensory Neurobiology (Including Visceral Nociception/

Pain, Neuroimmunology, Neurogenic Inflammation and Interactions With the Microbiome)

Obesity, Metabolism & Nutrition• Obesity: Basic and Mechanistic Studies• Obesity: Clinical and Epidemiological Studies

Pancreatic Disorders• Pancreas Cysts, IPMN and CP

Tuesday, May 9Cellular & Molecular Gastroenterology• Cell Biology, Biochemistry and Integrative Biology• Signaling Pathways Regulating Motility, Secretion

and Absorption

Clinical Practice• Epidemiology• Health-Care Delivery and Policy (Practice Management,

Reimbursement, Access to Care and Policy)

Esophageal, Gastric & Duodenal Disorders• Eosinophilic Esophagitis: Clinical, Translational or Basic• Mucosal Defense, Secretion, Injury, Repair and Healing

Gastrointestinal Oncology• Biomarkers for Detection, Treatment and Prognosis of GI

Cancers• Epidemiology and Population Health Screening: Colorectal

Cancer, Esophageal Cancer, Hepatocellular Carcinoma and Other Screening

Growth, Development & Child Health• Pediatric IBD: Clinical and Translational Studies

Imaging & Advanced Technology• Confocal Endomicroscopy and Other Optical Sectioning

Techniques II• Imaging of the GI Tract

Immunology, Microbiology & Inflammatory Bowel Diseases• Epithelial Cell Function in Inflammation• IBD: Epidemiology• IBD: Genomics and Gene Function• IBD: Microbiome• Mechanisms of Fibrosis• Microbial-Induced Mucosal Inflammation and Immunity• Mucosal Innate Immune Function and Innate Host Defense

Intestinal Disorders• Clostridium difficile Colitis• Irritable Bowel Syndrome

Liver & Biliary• Clinical Hepatitis: Etiology, Diagnosis and Natural History• Clinical Hepatitis: Prevention and Treatment• Complications of Cirrhosis and Portal Hypertension

Microbiome & Microbial Diseases in the Gastrointestinal Tract• Gut Microbiome–Based Therapies: Defined and Undefined• Microbiome and Cancer• The GI Microbiome: Determinants and Dynamics of Structure

and Function

Neurogastroenterology & Motility• Brain-Gut Axis (Including Neuroimaging, Vagal Pathways,

and Neurobiology of Satiety, Obesity and Metabolic Disorders)

• Enteric Neurobiology: Cell and Molecular Biology (Including Neurons, Glia, ICC, Smooth Muscle and Stem Cells)

• Functional Dyspepsia: Nausea and Vomiting

Obesity, Metabolism & Nutrition• Gut Microbial Regulation of Host Metabolic and Energy

Homeostasis• Regulation of Food Intake, Energy Expenditure and

Metabolic Function

Pancreatic Disorders• Pancreatitis: Inflammation, Fibrogenesis, Immunology

and Genetics

Maria T. Abreu, MD, AGAF, Chair

Cellular & Molecular GastroenterologyCharalabos Pothoulakis, MD, ChairLinda C. Samuelson, PhD, Vice Chair

Clinical PracticeJoel H. Rubenstein, MD, ChairPaul Moayyedi, MD, PhD, Vice Chair

Esophageal, Gastric & Duodenal DisordersMichael Frederick Vaezi, MD, PhD, ChairJohn Kao, MD, AGAF, Vice Chair

Growth, Development & Child HealthNoah F. Shroyer, PhD, ChairMaria Oliva-Hemker, MD, Vice Chair

Gastrointestinal OncologyRhonda F. Souza, MD, AGAF, ChairJohn P. Lynch, MD, PhD, Vice Chair

Imaging & Advanced TechnologyJohn M. DeWitt, MD, AGAF, ChairJacques Van Dam, MD, PhD, AGAF, Vice Chair

Immunology, Microbiology & Inflammatory Bowel DiseasesMark S. Silverberg, MD, PhD, ChairUma Mahadevan, MD, AGAF, Vice Chair

Intestinal DisordersWayne I. Lencer, MD, AGAF, ChairJoseph A. Murray, MD, Vice Chair

Liver & BiliaryJayant A. Talwalkar, MD, MPH, ChairKenneth E. Sherman, MD, PhD, Vice Chair

Microbiome & Microbial Diseases in the Gastrointestinal TractEugene B. Chang, MD, AGAF, ChairTor Christopher Savidge, PhD, Vice Chair

Neurogastroenterology & MotilitySatish S. C. Rao, MD, PhD, AGAF, ChairJohn Wiley, MD, Vice Chair

Obesity, Metabolism & NutritionDennis D. Black, MD, ChairSandeep Gupta, MD, AGAF, Vice Chair

Pancreatic DisordersSanthi S. Vege, MD, AGAF, FACG, FACP, ChairSteven D. Freedman, MD, PhD, Vice Chair

Thank You to Our CouncilThe programming in this booklet would not be possible without the members of our distinguished council:

Poster SessionsPOSTER SESSIONS 9:30 A.M.–4 P.M.

Poster SessionsPOSTER SESSIONS 9:30 A.M.–4 P.M.

26 27

NotesNotes

4930 Del Ray Ave.Bethesda, MD 20814